Skip to main content

Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice.

Grant PR, Kitchen A, Barbara JA, Hewitt P, Sims CM, Garson JA, Tedder RS

Publication: Vox Sang (2000) • Vol 78 • Page 137-42PMID: 10838513View on PubMed

Purpose

The purpose of this paperwas to determine the stability of hepatitis C virus (HCV) RNA in blood in the presence of different anticoagulants under a variety of storage temperatures and durations prior to processing.

Conclusion

HCV RNA levels declined significantly in blood specimens collected in tubes containing CPDA-1 and EDTA and stored at 37 degrees C for 120 hours. HCV RNA was stable at all other storage temperatures and durations.

Studies (1)

Purpose

The purpose of this study was to determine the stability of HCV RNA in blood in the presence of different anticoagulants under a variety of storage temperatures and durations prior to processing.

Summary of Findings

HCV RNA levels declined significantly in blood specimens collected in tubes containing CPDA-1 and K3EDTA and stored at 37 degrees C for 120 hours. HCV RNA was stable at all other storage temperatures and durations.

  • Biospecimens

    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Hepatitis
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate phosphate dextrose adenine 1
    Plasma preparation tubes (PPT)
    Potassium EDTA
    StorageStorage duration
    0 h
    120 h
    16 h
    24 h
    48 h
    72 h
    8 h
    96 h
    StorageStorage temperature
    25 degrees C
    37 degrees C
    4 degrees C